Allelic Selection of Amplicons in Glioblastoma Revealed by Combining Somatic and Germline Analysis

English version České info

Cancer is a disease driven by a combination of inherited risk alleles coupled with the acquisition of somatic mutations, including amplification and deletion of genomic DNA. Potential relationships between the inherited and somatic aspects of the disease have only rarely been examined on a genome-wide level. Applying a novel integrative analysis of SNP and copy number measurements, we queried the tumor and normal-tissue genomes of 178 glioblastoma patients from the Cancer Genome Atlas project for preferentially amplified alleles, under the hypothesis that oncogenic germline variants will be selectively amplified in the tumor environment. Selected alleles are revealed by allelic imbalance in amplification across samples. This general approach is based on genetic principles and provides a method for identifying important tumor-related alleles. We find that SNP alleles that are most significantly overrepresented in amplicons tend to occur in genes involved with regulation of kinase and transferase activity, and many of these genes are known contributors to gliomagenesis. The analysis also implicates variants in synapse genes. By incorporating gene expression data, we demonstrate synergy between preferential allelic amplification and expression in DOCK4 and EGFR. Our results support the notion that combining germline and tumor genetic data can identify regions relevant to cancer biology.

Vyšlo v časopise: Allelic Selection of Amplicons in Glioblastoma Revealed by Combining Somatic and Germline Analysis. PLoS Genet 6(9): e32767. doi:10.1371/journal.pgen.1001086
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1001086

Souhrn

Zdroje

1. NowellPC

1976 The clonal evolution of tumor cell populations. Science 194 23 28

2. de KoningJP

WakabayashiY

NagaseH

MaoJH

BalmainA

2007 Convergence of congenic mapping and allele-specific alterations in tumors for the resolution of the Skts1 skin tumor susceptibility locus. Oncogene 26 4171 4178

3. NagaseH

MaoJH

BalmainA

2003 Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid mice. Cancer Res 63 4849 4853

4. Ewart-TolandA

BriassouliP

de KoningJP

MaoJH

YuanJ

2003 Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nat Genet 34 403 412

5. HienonenT

SalovaaraR

MecklinJP

JarvinenH

KarhuA

2006 Preferential amplification of AURKA 91A (Ile31) in familial colorectal cancers. Int J Cancer 118 505 508

6. TuupanenS

NiittymakiI

NousiainenK

VanharantaS

MecklinJP

2008 Allelic imbalance at rs6983267 suggests selection of the risk allele in somatic colorectal tumor evolution. Cancer Res 68 14 17

7. OlcayduD

HarutyunyanA

JagerR

BergT

GisslingerB

2009 A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms. Nat Genet

8. KilpivaaraO

MukherjeeS

SchramAM

WadleighM

MullallyA

2009 A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms. Nat Genet 41 455 459

9. JonesAV

ChaseA

SilverRT

OscierD

ZoiK

2009 JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms. Nat Genet 41 446 449

10. DewalN

FreedmanML

LaFramboiseT

Pe'erI

2010 Power to detect selective allelic amplification in genome-wide scans of tumor data. Bioinformatics 26 518 528

11. SpielmanRS

McGinnisRE

EwensWJ

1993 Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52 506 516

12. LaFramboiseT

WeirBA

ZhaoX

BeroukhimR

LiC

2005 Allele-specific amplification in cancer revealed by SNP array analysis. PLoS Comput Biol 1 e65 doi:10.1371/journal.pcbi.0010065

13. 2008 Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455 1061 1068

14. AshburnerM

BallCA

BlakeJA

BotsteinD

ButlerH

2000 Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25 25 29

15. WrenschM

JenkinsRB

ChangJS

YehRF

XiaoY

2009 Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41 905 908

16. PriceAL

PattersonNJ

PlengeRM

WeinblattME

ShadickNA

2006 Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38 904 909

17. GomesAL

Reis-FilhoJS

LopesJM

MartinhoO

LambrosMB

2007 Molecular alterations of KIT oncogene in gliomas. Cell Oncol 29 399 408

18. HoltkampN

ZiegenhagenN

MalzerE

HartmannC

GieseA

2007 Characterization of the amplicon on chromosomal segment 4q12 in glioblastoma multiforme. Neuro Oncol 9 291 297

19. SihtoH

TynninenO

ButzowR

Saarialho-KereU

JoensuuH

2007 Endothelial cell KIT expression in human tumours. J Pathol 211 481 488

20. ReardonDA

DresemannG

TaillibertS

CamponeM

van den BentM

2009 Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma. Br J Cancer 101 1995 2004

21. RazisE

SelviaridisP

LabropoulosS

NorrisJL

ZhuMJ

2009 Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment. Clin Cancer Res 15 6258 6266

22. VerhaakRG

HoadleyKA

PurdomE

WangV

QiY

2010 Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17 98 110

23. YajnikV

PauldingC

SordellaR

McClatcheyAI

SaitoM

2003 DOCK4, a GTPase activator, is disrupted during tumorigenesis. Cell 112 673 684

24. HeasmanSJ

RidleyAJ

2008 Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol 9 690 701

25. UedaS

FujimotoS

HiramotoK

NegishiM

KatohH

2008 Dock4 regulates dendritic development in hippocampal neurons. J Neurosci Res 86 3052 3061

26. JarzynkaMJ

HuB

HuiKM

Bar-JosephI

GuW

2007 ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion. Cancer Res 67 7203 7211

27. HuangPH

XuAM

WhiteFM

2009 Oncogenic EGFR signaling networks in glioma. Sci Signal 2 re6

28. EkstrandAJ

SugawaN

JamesCD

CollinsVP

1992 Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc Natl Acad Sci U S A 89 4309 4313

29. WongAJ

BignerSH

BignerDD

KinzlerKW

HamiltonSR

1987 Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci U S A 84 6899 6903

30. BrandesAA

FranceschiE

TosoniA

HegiME

StuppR

2008 Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments. Clin Cancer Res 14 957 960

31. MellinghoffIK

WangMY

VivancoI

Haas-KoganDA

ZhuS

2005 Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med 353 2012 2024